These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 3579161)

  • 1. [Purification of antithrombin III by affinity chromatography in heparin-Trisacryl].
    Allary M; Boschetti E; Majurel M; Girot P; Saint-Blancard J
    Ann Pharm Fr; 1986; 44(5):379-86. PubMed ID: 3579161
    [No Abstract]   [Full Text] [Related]  

  • 2. Three novel high performance affinity chromatographic media for the separation of antithrombin III from human plasma.
    Zhao Y; Zhao R; Shangguan D; Xiong S; Liu G
    Biomed Chromatogr; 2001 Dec; 15(8):487-92. PubMed ID: 11748680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Separation and purification of antithrombin III, thrombin and carboxypeptidase N using affinity sorption on the copolymer hydroxyalkylmethacrylate with immobilized heparin (heparinoid)].
    Rybák M; Coupek J
    Cesk Farm; 1982 Jan; 31(1):27-9. PubMed ID: 6176339
    [No Abstract]   [Full Text] [Related]  

  • 4. Capillary affinity chromatography and affinity capillary electrophoresis of heparin binding proteins.
    Wu X; Linhardt RJ
    Electrophoresis; 1998 Nov; 19(15):2650-3. PubMed ID: 9848674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A highly purified antithrombin III concentrate prepared from human plasma fraction IV-1 by affinity chromatography.
    Lebing WR; Hammond DJ; Wydick JE; Baumbach GA
    Vox Sang; 1994; 67(2):117-24. PubMed ID: 7801599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification and characterization of hereditary abnormal antithrombin III with impaired thrombin binding.
    Jørgensen M; Petersen LC; Thorsen S
    J Lab Clin Med; 1984 Aug; 104(2):245-56. PubMed ID: 6747440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High and low anticoagulant activity heparins. Preparation in large scale and degree of complexation with antithrombin III.
    Takahashi HK; Nader HB; Dietrich CP
    Arzneimittelforschung; 1985; 35(11):1620-3. PubMed ID: 4091864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification of antithrombin 'Vicenza': a molecule with normal heparin affinity and impaired reactivity to thrombin.
    Finazzi G; Tran TH; Barbui T; Duckert F
    Br J Haematol; 1985 Feb; 59(2):259-63. PubMed ID: 3970857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immobilization of heparin with trichloro-s-triazine: purification of mouse antithrombin.
    Finlay TH; Troll V; Hodgins LT
    Anal Biochem; 1980 Nov; 108(2):354-9. PubMed ID: 7457881
    [No Abstract]   [Full Text] [Related]  

  • 10. A novel matrix for high performance affinity chromatography and its application in the purification of antithrombin III.
    Zhao R; Luo J; Shangguan D; Liu G
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Feb; 816(1-2):175-81. PubMed ID: 15664348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification and characterization of guinea pig antithrombin III.
    Clement LT
    Prep Biochem; 1983; 13(1):1-20. PubMed ID: 6856582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Affinity chromatography in the separation of human alpha 1-antitrypsin (alpha 1-AT) and antithrombin-III (AT-III).
    D'Souza S; Ananthakrishnan R
    Aust J Exp Biol Med Sci; 1979 Jun; 57(3):245-50. PubMed ID: 316999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homozygous variant of antithrombin III: AT III Fontainebleau.
    Boyer C; Wolf M; Vedrenne J; Meyer D; Larrieu MJ
    Thromb Haemost; 1986 Aug; 56(1):18-22. PubMed ID: 3775688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of membrane adsorber (MA) based purification schemes for the down-stream processing of recombinant h-AT III.
    Reif OW; Freitag R
    Bioseparation; 1994 Dec; 4(6):369-81. PubMed ID: 7765681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphotungstate as a useful eluent for antithrombin III purification by heparin-agarose affinity chromatography.
    Tajima Y; Shizuka R; Oshitani S; Amagai H
    Thromb Res; 1990 Mar; 57(5):697-704. PubMed ID: 2339364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Procedures for the isolation and characterization of human antithrombin III].
    Trobisch H; Wüst T; Rustige H
    Behring Inst Mitt; 1986 Feb; (79):177-90. PubMed ID: 3718405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation of plasma proteins from the clotting cascade by heparin affinity chromatography.
    Josić D; Bal F; Schwinn H
    J Chromatogr; 1993 Feb; 632(1-2):1-10. PubMed ID: 8454710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization and viral safety validation study of a pasteurized therapeutic concentrate of antithrombin III obtained through affinity chromatography.
    Biescas H; Gensana M; Fernández J; Ristol P; Massot M; Watson E; Vericat F
    Haematologica; 1998 Apr; 83(4):305-11. PubMed ID: 9592979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological activities of heparins obtained from different tissues: enrichment of heparin fractions with high lipoprotein lipase, antihemolytic and anticoagulant activities by molecular sieving and antithrombin III affinity chromatography.
    Bianchini P; Osima B; Parma B; Nader HB; Dietrich CP
    J Pharmacol Exp Ther; 1982 Feb; 220(2):406-10. PubMed ID: 7057400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation of three types of heparin-sepharose and their binding activities to thrombin and antithrombin III.
    Funahashi M; Matsumoto I; Seno N
    Anal Biochem; 1982 Nov; 126(2):414-21. PubMed ID: 7158775
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.